U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9564195641Safety Study of Flufirvitide-3 Nasal Spray in Healthy SubjectsCompletedNo Results AvailableInfluenzaDrug: Flufirvitide-3 0.05 mg single dose|Drug: Flufirvitide-3, 0.1 mg single dose|Drug: Flufirvitide-3, 0.2 mg single dose|Drug: Flufirvitide-3, 0.4 mg single dose|Other: Placebohttps://ClinicalTrials.gov/show/NCT01313962
9564295642PLATINUM Program: A Feasibility Study on a Train-the-trainer Course on Peer Support for People With Type 2 DiabetesCompletedNo Results AvailableDiabetesOther: Training programhttps://ClinicalTrials.gov/show/NCT01313949
9564395643High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed NeuroblastomaCompletedHas ResultsNeuroblastomaDrug: Metaiodobenzylguanidine (MIBG)https://ClinicalTrials.gov/show/NCT01313936
9564495644Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis PemphigusRecruitingNo Results AvailablePemphigusDrug: Sirolimus (formerly known as Rapamycin)https://ClinicalTrials.gov/show/NCT01313923
9564595645CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® SupplementsActive, not recruitingNo Results AvailableHIVDietary Supplement: Immunolin®https://ClinicalTrials.gov/show/NCT01313910
9564695646UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple MyelomaRecruitingNo Results AvailableMultiple MyelomaDrug: Bortezomibhttps://ClinicalTrials.gov/show/NCT01313897
9564795647Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings SarcomaTerminatedNo Results AvailableBone Cancer|Ewing's SarcomaDrug: Irinotecan|Drug: Vincristine|Drug: Temozolomide|Drug: Doxorubicin|Drug: Cytoxan|Drug: Pegfilgrastim|Drug: Mesnahttps://ClinicalTrials.gov/show/NCT01313884
9564895648Assessment of the Disease Severity and Treatment Patterns of Rheumatoid Arthritis in Eastern Europe, Middle East and North African Countries (P08167)WithdrawnNo Results AvailableArthritis, Rheumatoidhttps://ClinicalTrials.gov/show/NCT01313871
9564995649A Study to Investigate the Use of Simponi® in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)Active, not recruitingNo Results AvailableArthritis, Rheumatoid|Arthritis, Psoriatic|Spondylitis, AnkylosingDrug: Simponi®https://ClinicalTrials.gov/show/NCT01313858
9565095650Effect of Intravenous Amantadine on Gait Freezing in Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDrug: amantadine sulfate|Drug: 0.9% sodium chloridehttps://ClinicalTrials.gov/show/NCT01313845
9565195651The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary HypertensionCompletedNo Results AvailableVentricular Septal Defect|Pulmonary HypertensionOther: remote ischemic preconditioning (RIPC)https://ClinicalTrials.gov/show/NCT01313832
9565295652The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic TherapyRecruitingNo Results AvailableParkinson`s Disease|Freezing of GaitDrug: PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml injhttps://ClinicalTrials.gov/show/NCT01313819
9565395653Study of Magnetic Fields to Treat Alzheimer's DiseaseWithdrawnNo Results AvailableAlzheimer's DiseaseDevice: Resonator|Device: Placebohttps://ClinicalTrials.gov/show/NCT01313806
9565495654A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804CompletedNo Results AvailableHealthy VolunteersDrug: Treatment A-B|Drug: Treatment B-Ahttps://ClinicalTrials.gov/show/NCT01313793
9565595655A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer PatientsCompletedNo Results AvailableCancerDrug: oxycodone and naloxonehttps://ClinicalTrials.gov/show/NCT01313780
9565695656MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb SpasticityCompletedNo Results AvailableSpasticityDrug: Botulinum toxin type A|Drug: Botulinum Toxin type Ahttps://ClinicalTrials.gov/show/NCT01313767
9565795657Comparison of Skin Incision Closure Material for the Transobturator Suburethral Sling ProcedureCompletedNo Results AvailablePain, Postoperative|Irritation (Physical)|Pelvic PainProcedure: Vicryl Suture|Procedure: Dermabondhttps://ClinicalTrials.gov/show/NCT01313754
9565895658This is a 2 Year Follow up Clinical and Radiographic Analysis of a Novel All Polyethelene Glenoid Component in Standard Total Shoulder Arthroplasty.Not yet recruitingNo Results AvailableThe Primary Disease Process Being Studied is Shoulder OA and the Effect of an All Polyethelene Glenoid Component on Shoulder ArthroplastyDevice: Shoulder arthroplasty with anchor peg glenoidhttps://ClinicalTrials.gov/show/NCT01313741
9565995659A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment ProductsCompletedHas ResultsAcne VulgarisDrug: Dapsone plus Tretinoin Gel|Drug: Tretinoin Gelhttps://ClinicalTrials.gov/show/NCT01313728
9566095660A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and InfantsCompletedNo Results AvailableHand, Foot, and Mouth Disease|Enterovirus InfectionsBiological: 160U /0.5ml|Biological: 320U /0.5ml|Biological: 640U /0.5ml|Biological: 0/0.5ml placebohttps://ClinicalTrials.gov/show/NCT01313715
9566195661Single Pill to Avert Cardiovascular EventsNot yet recruitingNo Results AvailableCardiovascular DiseaseDrug: polipillV1|Drug: polipillV2|Drug: usual carehttps://ClinicalTrials.gov/show/NCT01313702
9566295662Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic LeukemiaActive, not recruitingHas ResultsLeukaemia, Lymphocytic, ChronicDrug: Ofatumumab|Drug: Physicians' Choicehttps://ClinicalTrials.gov/show/NCT01313689
9566395663Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: fluticasone furoate/vilanterol|Drug: fluticasone furoate|Drug: vilanterol|Other: Placebohttps://ClinicalTrials.gov/show/NCT01313676
9566495664A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) PopulationTerminatedHas ResultsLung Cancer, Small CellDrug: pazopanib|Drug: pemetrexedhttps://ClinicalTrials.gov/show/NCT01313663
9566595665A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPDCompletedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: 62.5/25mcg|Drug: 62.5mcg|Drug: 25mcg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01313650
9566695666A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPDCompletedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: GSK573719/GW642444 125/25mcg|Drug: GSK573719 125mcg|Drug: GW642444 25mcg|Drug: Placebo onlyhttps://ClinicalTrials.gov/show/NCT01313637
9566795667Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis BronchiectasisCompletedHas ResultsBronchiectasisDrug: AZLI|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01313624
9566895668BRIEF Bendamustine and Rituximab In Elderly FollicularTerminatedNo Results AvailableFollicular LymphomaDrug: Rituximab + bendamustinehttps://ClinicalTrials.gov/show/NCT01313611
9566995669GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid TumorsCompletedNo Results AvailableSolid TumorsDrug: GLPG0187https://ClinicalTrials.gov/show/NCT01313598
9567095670Device Mixing in Asthma, a General Practice Research Database StudyCompletedNo Results AvailableAsthmaDrug: Initiation of beclometasone via the Easibreathe device plus salbutamol via the Easibreathe device|Drug: Initiation of beclometasone via the Easibreathe device plus salbutamol via and MDI device|Drug: Increase of beclometasone via the Easibreathe device plus salbutamol via the Easibreathe device|Drug: Increase of beclometasone via the Easibreathe device plus salbutamol via an MDIhttps://ClinicalTrials.gov/show/NCT01313585

* Görseller ve İçerik tekif hakkına sahip olabilir